Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

BGIICC 2018 /
BGICC conference highlights: Changing standards in breast and gynaecological cancers

18th - 19th Jan 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.01.18
Views: 1744

Dr Hesham El Ghazaly - Ain Shams University, Cairo, Egypt

Dr Ghazaly, general secretary of the 10th BGICC in Cairo, meets with ecancer to discuss key topics from the conference sessions.

He hightlights the drug discovery sessions focussing on the latest generation of tyrosine kinase inhibitors now available, ongoing trials of targetted PD-1/PD-L1 checkpoint inhibitors, and panel discussions of disease prevention.

Dr Ghazaly notes the number of young conference attendees, which has informed programme sessions in next years conference to include mentoring and training opportunities.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation